CheckMan Stock Market Overview

Dime Community Bancshares NASDAQ: DCOM reported record third-quarter revenue of $135 million and said earnings per share increased 53% from a year earlier, as the company continued to expand its business-lending platform, grow core deposits and improve its net interest margin.

Hasbro NASDAQ: HAS reported third-quarter revenue growth of 15% and a 52% increase in adjusted operating profit, led by continued momentum at Wizards of the Coast and Digital Gaming and improved profitability in Consumer Products.

Vicor NASDAQ: VICR reported sharply higher third-quarter revenue and profitability, supported by growth in advanced products and royalty income, while management outlined further capacity expansion plans to address demand tied to artificial-intelligence infrastructure and other markets.

Washington Trust Bancorp NASDAQ: WASH reported higher third-quarter earnings, net interest income and net interest margin, while credit-quality measures improved following the restructuring of a commercial real estate office loan.

GE Aerospace NYSE: GE raised its full-year outlook after reporting third-quarter growth in orders, revenue, profit and free cash flow, supported by continued demand for commercial engine services and improving production output.

General Motors NYSE: GM reported record third-quarter revenue and higher adjusted earnings, while raising its outlook for adjusted automotive free cash flow and authorizing a new $20 billion multiyear share-repurchase program.

Synchrony Financial NYSE: SYF reported third-quarter net earnings of $892 million, or $2.68 per diluted share, as purchase volume reached nearly $50 billion and rose across each of the company's five sales platforms.

Valmont Industries NYSE: VMI reported higher third-quarter sales, operating profit and earnings, led by growth in its North American utility and coatings businesses, while management raised its full-year adjusted earnings outlook despite expected fourth-quarter pressure from higher input costs and business mix.

Korro and Tevard outlined approaches designed to expand the therapeutic use of RNA medicines beyond protein silencing, highlighting programs that aim to repair genetic defects or restore production of full-length proteins.

Mirion Technologies (MIR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.